Daiichi Sankyo Company (4568-TO)

The Economic Times  Apr 17  Comment 
The Singh brothers said court orders are not applicable to Religare as it is not party to the Japanese drug maker’s case to recover Rs 3,500 crore from them as part of an arbitration award.
The Economic Times  Mar 29  Comment 
Daiichi seeks court nod to induct external auditor to inspect the financial details disclosed by former Ranbaxy owners in the $500-mn arbitration award case.
The Economic Times  Mar 20  Comment 
Daiichi’s counsel alleged that the Singhs made false statements in affidavits about unencumbered assets of RHC Holding, the holding company for the brothers.
The Economic Times  Feb 28  Comment 
Justice S Muralidhar has directed the brothers to file a reply to Daiichi's allegations before the next hearing of the case on March 6, when Daiichi's latest plea is to be heard.
The Economic Times  Jan 22  Comment 
Oscar Traders was one of 20 respondents linked to the brothers from whom Daiichi is trying to recover the money awarded to it by a Singapore arbitration tribunal last year.
The Hindu Business Line  Jan 17  Comment 
Daiichi Sankyo had sought a stay on plans by Malvinder and Shivinder Singh to sell over 26% in the healthcare firm
The Economic Times  Jan 16  Comment 
Daiichi’s move comes as the Singh brothers look to induct an investor in Fortis Healthcare.
newratings.com  Jan 12  Comment 
TOKYO (dpa-AFX) - Daiichi Sankyo Company Limited (DSKYF.PK)reported that its profit attributable to owners of the company for the first nine months of fiscal 2016 decreased 20.4 percent to 88.18 billion yen from 110.73 billion yen in the same...
GenEng News  Jan 10  Comment 
Kite Pharma has negotiated separate agreements with Fosun Pharma and with Daiichi Sankyo for the development of its lead CD19 chimeric antigen receptor (CAR) T-cell autologous cell therapy, axicabtagene ciloleucel (KTE-C19), in Japan and China,...

You may also be interested in articles related to Daiichi Sankyo Company (4568-TO):
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki